Bioprobe Diagnostics have successfully completed an exclusive licence agreement with NUI Galway for use of a molecular diagnostic patent in Europe and the USA. This licence enables access to the proprietary IP at the core of Bioprobe’s launch product Bio-Lp-1. The licence permits use of the IP in environmental and Industrial applications.
